Chroman-4-amine

Catalog No.: 
ACVXNF497
CAS No.: 
53981-38-7
Molecular Formula: 
C9H11NO
Molecular Weight: 
149.19
Chroman-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$106.00In stockIn stock
25g97%$493.00In stockIn stock
100g97%$1913.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameChroman-4-amine
IUPAC Namechroman-4-amine
MDL No.MFCD00730969
Molecular FormulaC9H11NO
Molecular Weight149.19
SMILESNC1CCOC2=C1C=CC=C2
InChI KeyLCOFMNJNNXWKOC-UHFFFAOYSA-N
SynonymChroman-4-amine | Chroman-4-ylamine | 53981-38-7 | 3,4-dihydro-2H-chromen-4-ylamine | 3,4-dihydro-2H-chromen-4-amine | 4-aminochromane | 3,4-dihydro-2H-1-benzopyran-4-amine | MFCD00730969 | 4-AMINOCHROMAN | 4-chromanamine | MFCD06761756 | 2H-1-BENZOPYRAN-4-AMINE, 3,4-DIHYDRO- |
CAS No.53981-38-7
PubChem CID4961957

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACVXNF497 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCHVR308 route compound structure diagram
    ACCHVR308491-37-2In Stock
  2. Then
  3. ACVXNF497 route product structure diagram
    ACVXNF49753981-38-7In Stock
Inquiry

2. ACVXNF497 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. ACCHVR308 route compound structure diagram
    ACCHVR308491-37-2In Stock
  4. Then
  5. ACVXNF497 route product structure diagram
    ACVXNF49753981-38-7In Stock
Inquiry

3. ACVXNF497 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPYML318 route compound structure diagram
    ACPYML3181481-93-2In Stock
  2. Then
  3. ACVXNF497 route product structure diagram
    ACVXNF49753981-38-7In Stock
Inquiry

Comments (0)